TrialHaematologica2026

Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center.

Betül Oran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.